1 We examined A3 adenosine and CB1 cannabinoid receptor-coupled signaling pathways regulating Cl À current in a human nonpigmented ciliary epithelial (NPCE) cell line. 2 Whole-cell patch-clamp recordings demonstrated that the A3 receptor agonist, IB-MECA, activates an outwardly rectifying Cl À current (I Cl,Aden ) in NPCE cells, which was inhibited by the adenosine receptor antagonist, CGS-15943 or by the protein kinase C (PKC) activator, phorbol 12,13 dibutyrate (PDBu). 3 Treatment of NPCE cells with pertussis-toxin (PTX), or transfection with the COOH-terminus of b-adrenergic receptor kinase (ct-bARK), inhibited I Cl,Aden . The phosphatidyl inositol 3-kinase (PI3K) inhibitor, wortmannin, had no effect on I Cl,Aden ; however, the mitogen-activated protein kinase kinase (MEK) inhibitor, PD98059, inhibited I Cl,Aden . 4 Reverse transcription -polymerase chain reaction experiments and immunocytochemistry confirmed mRNA and protein expression for the CB1 receptor in NPCE cells, and the CB1 receptor agonist, Win 55,212-2, activated a PDBu-sensitive Cl À current (I Cl,Win ). 5 Transfection of NPCE cells with the human CB1 (hCB1) receptor, increased I Cl,Win , consistent with increased receptor expression, and I Cl,Win in hCB1 receptor-transfected cells was decreased after application of a CB1 receptor inverse agonist, SR 141716. 6 Constitutive activity for CB1 receptors was not significant in NPCE cells as transfection with hCB1 receptors did not increase basal Cl À current, nor was basal current inhibited by SR 141716. 7 I Cl,Win was inhibited by PTX preincubation, by transfection with ct-bARK and by the MEK inhibitor, PD98059, but unaffected by the PI3K inhibitor, wortmannin. 8 We conclude that both A3 and CB1 receptors activate a PKC-sensitive Cl À current in human NPCE cells via a G i/o /Gbg signaling pathway, in a manner independent of PI3K but involving MAPK.